A survey of 215 non-hemophilic patients with inhibitors to factor VIII

Keyphrases

• Alkylating Agents 50%
• Allergy 50%
• Antihemophilic Factor 50%
• Asthma 50%
• Autoimmune Disease 100%
• Being Present 50%
• Corticosteroids 100%
• Cyclophosphamide 50%
• During Pregnancy 50%
• Factor VIII Concentrate 50%
• Favorable Outcome 50%
• Hemophilia Patients 100%
• Major Bleeding 50%
• Malignancy 50%
• Number of Females 50%
• Number of Males 50%
• Patient-specific Therapy 50%
• Penicillin 50%
• Postpartum Patient 50%
• Postpartum Period 50%
• Potential Therapeutics 50%
• Rheumatoid Arthritis 100%
• Steroid Therapy 50%
• Transfusion 50%
• Underlying Disorders 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Alkylating Agent 33%
• Asthma 33%
• Autoimmune Disease 66%
• Azathioprine 33%
• Bleeding 33%
• Blood Clotting Factor 8 100%
• Blood Clotting Factor 8 Concentrate 33%
• Cyclophosphamide 33%
• Diseases 33%
• Inflammatory Arthritis 66%
• Penicillin 33%
• Rheumatoid Arthritis 66%

Immunology and Microbiology

• Asthma 33%
• Autoimmune Disease 66%
• Azathioprine 33%
• Cyclophosphamide 33%
• Factor VIII 100%
• Inflammatory Arthritis 66%
• Penicillin 33%
• Puerperium 33%